3050-7081

EULAR Rheumatology Open

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 213 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact213 DOIs
2

Attach ORCID iDs across 21 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact21 DOIs
3

Deposit reference lists for 13 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact13 DOIs

DOIs for this ISSN

Showing the top 5 of 213 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Comparative analysis of large language models and traditiona… (10.1016/j.ero.2025.04.007)
Abstract
28.65 13
2 CD19-targeting CAR T cell therapy in five patients with syst… (10.1016/j.ero.2025.03.005)
Abstract
23.86 8
3 From chat to act: large language model agents and agentic AI… (10.1016/j.ero.2025.06.012)
Abstract
19.45 5
4 Reproductive Health in Rheumatology: Making ‘Early and Regul… (10.1016/j.ero.2025.06.001)
Abstract
17.47 4
5 Management of systemic lupus erythematosus with kidney invol… (10.1016/j.ero.2025.07.006)
Abstract
17.47 4
6 Optimising the clinical application of rheumatology guidelin… (10.1016/j.ero.2025.08.001)
Abstract
17.47 4
7 Management of mucocutaneous and joint involvement of Behçet’… (10.1016/j.ero.2026.02.017)
Abstract
17.47 4
8 Early management of hemophagocytic lymphohistiocytosis/macro… (10.1016/j.ero.2025.04.004)
Abstract
15.05 3
9 Comparison of the PK, PD, safety, tolerability, and immunoge… (10.1016/j.ero.2025.08.006)
Abstract ORCID
15.05 1
10 Rapid and profound treatment response of difficult-to-treat… (10.1016/j.ero.2025.08.008)
Abstract
15.05 3
11 Management of major organ involvement in Behçet syndrome: a… (10.1016/j.ero.2026.02.019)
Abstract
15.05 3
12 Molecular imaging and immune cell adhesion via vascular adhe… (10.1016/j.ero.2025.04.005)
Abstract
11.93 2
13 Difficult-to-treat or clinical inertia?: the importance of e… (10.1016/j.ero.2025.06.002)
Abstract
11.93 2
14 The patient journey in rheumatic and musculoskeletal disease… (10.1016/j.ero.2025.06.010)
Abstract
11.93 2
15 Pregnancy outcomes of non-tumour necrosis factor inhibitor b… (10.1016/j.ero.2025.06.011)
Abstract
11.93 2
16 Methodology of the development of the EULAR Antiphosholipid… (10.1016/j.ero.2025.07.009)
Abstract
11.93 2
17 Long-term risk of malignancies in ANCA-associated vasculitis (10.1016/j.ero.2025.08.007)
Abstract
11.93 2
18 The association between ethnicity, socioeconomic position an… (10.1016/j.ero.2025.10.001)
Abstract
11.93 2
19 Interdisciplinary Clinical Practice Guidelines for patient-c… (10.1016/j.ero.2025.10.005)
Abstract
11.93 2
20 Patients’ coping strategies in the first 2 years of rheumato… (10.1016/j.ero.2025.11.008)
Abstract
11.93 2
21 Characterising subgroups of difficult-to-treat rheumatoid ar… (10.1016/j.ero.2025.11.024)
Abstract
11.93 2
22 Vitamin D supplementation: still a challenge for rheumatolog… (10.1016/j.ero.2025.02.001)
Abstract
7.53 1
23 Pregnancy-associated exposure reduction to medications used… (10.1016/j.ero.2025.03.001)
Abstract
7.53 1
24 Burden of fatigue in cryopyrin-associated periodic syndromes (10.1016/j.ero.2025.03.003)
Abstract
7.53 1
25 Differentiation of diffuse idiopathic skeletal hyperostosis… (10.1016/j.ero.2025.03.004)
Abstract
7.53 1
26 Living with a systemic autoinflammatory disease: burden of d… (10.1016/j.ero.2025.03.006)
Abstract
7.53 1
27 Clinical, biological, and radiological changes under therapy… (10.1016/j.ero.2025.05.001)
Abstract
7.53 1
28 Five years of the Digital Rheumatology Network: insights and… (10.1016/j.ero.2025.05.003)
Abstract
7.53 1
29 Items identified by expert physicians for the development of… (10.1016/j.ero.2025.05.004)
Abstract
7.53 1
30 Effectiveness and safety of antiresorptive drugs in patients… (10.1016/j.ero.2025.05.008)
Abstract
7.53 1
31 Feasibility of INSELMA: an interdisciplinary nurse-coordinat… (10.1016/j.ero.2025.06.008)
Abstract
7.53 1
32 Prevalence, outcomes, and predictive factors: a systematic l… (10.1016/j.ero.2025.07.007)
Abstract
7.53 1
33 On the edge of dependency: how older adults with rheumatoid… (10.1016/j.ero.2025.08.002)
Abstract
7.53 1
34 Clinical and imaging features of haemochromatosis arthropath… (10.1016/j.ero.2025.08.005)
Abstract
7.53 1
35 Individualised treatment effect prediction: the benefit of i… (10.1016/j.ero.2025.09.007)
Abstract
7.53 1
36 Differential joint-level response to secukinumab in psoriati… (10.1016/j.ero.2025.09.009)
Abstract
7.53 1
37 Patient perspectives on glucocorticoid-associated complicati… (10.1016/j.ero.2025.10.006)
Abstract
7.53 1
38 EGPAware: a European Delphi consensus study on red flags for… (10.1016/j.ero.2025.11.014)
Abstract
7.53 1
39 The EULAR points to consider regarding the development of cr… (10.1016/j.ero.2025.11.015)
Abstract
7.53 1
40 Healthcare professionals’ perspectives on digital biomarkers… (10.1016/j.ero.2025.11.021)
Abstract
7.53 1
41 Antirheumatic medication use among pregnant women with rheum… (10.1016/j.ero.2025.11.023)
Abstract
7.53 1
42 Spondyloarthritis and inflammatory bowel disease: towards a… (10.1016/j.ero.2025.12.001)
Abstract
7.53 1
43 Understanding the transition from psoriasis to psoriatic art… (10.1016/j.ero.2025.12.008)
Abstract
7.53 1
44 Examining emergency department utilisation in people with Cr… (10.1016/j.ero.2026.01.007)
Abstract
7.53 1
45 Open-access clinic for arthralgia: patient flow and diagnost… (10.1016/j.ero.2026.02.003)
Abstract
7.53 1
46 Early progression of systemic sclerosis: a longitudinal coho… (10.1016/j.ero.2026.02.006)
Abstract
7.53 1
47 Unravelling complex relationships between health literacy an… (10.1016/j.ero.2026.02.014)
Abstract
7.53 1
48 Costochondritis in relapsing polychondritis (10.1016/j.ero.2025.01.001)
Abstract
0.00 0
49 Skin and bone: a mysterious link to an underdiagnosed cause… (10.1016/j.ero.2025.02.002)
Abstract
0.00 0
50 Chronic polydipsia and polyuria as rare renal manifestations… (10.1016/j.ero.2025.03.002)
Abstract
0.00 0